Impact of COVID-19 pandemic on screening and diagnosis of patients with prostate cancer: a systematic review protocol.

ABSTRACT:

Introduction

With the exponential progress of patients with COVID-19, unexpected restrictions were directed to limit SARS-CoV-2 dissemination and imposed health-system an entire reformation to diminish transmission risk. These changes likely have caused the full range of cancer screenings and diagnosis gaps. Regardless of the recommendations, prostate cancer (PCa) screening/diagnosis programmes were momentarily postponed. Prostate-specific antigen (PSA) testing has been an inexpensive, low-invasive and relatively precise means of detection for PCa screening that would improve the uncovering of any type of PCa. Unfortunately, a decrease in PSA screening would significantly decrease PCa detection, with non-negligible growth in PCa-specific death. This review is designed to improve ou

SUBMITTER: Mostafavi Zadeh SM 

PROVIDER: S-EPMC9421918 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature